Meridian Bioscience (VIVO) Misses Q4 EPS by 1c
Tweet
Share
E-mailGet Alerts VIVO Hot Sheet
Price: $4.87 +6.10%
Financial Fact:
AVERAGE NUMBER OF COMMON SHARES OUTSTANDING - DILUTED: -84.82M
Today's EPS Names:
SVBT, ZEO, OTLK, More
Financial Fact:
AVERAGE NUMBER OF COMMON SHARES OUTSTANDING - DILUTED: -84.82M
Today's EPS Names:
SVBT, ZEO, OTLK, More
Join SI Premium – FREE
Meridian Bioscience (NASDAQ: VIVO) reported Q4 EPS of $0.20, $0.01 worse than the analyst estimate of $0.21. Revenue for the quarter came in at $47.1 million versus the consensus estimate of $46.6 million.
For earnings history and earnings-related data on Meridian Bioscience (VIVO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
- Newton Golf Company (NWTG) Reports Q2 Loss of $0.49
- Neumora Therapeutics, Inc. (NMRA) Tops Q2 EPS by 4c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
